Company Filing History:
Years Active: 2016
Title: Olav Michael Anderson: Innovator in Neurotrophin Modulation
Introduction
Olav Michael Anderson is a notable inventor based in Skamby, Denmark. He has made significant contributions to the field of neurobiology through his innovative work on neurotrophins. His research focuses on developing agents that can inhibit the binding of pro-neurotrophins to specific receptors, which has implications for treating various diseases.
Latest Patents
Anderson holds a patent for the invention titled "Modulation of activity of proneurotrophins." This patent provides agents designed to inhibit the binding of pro-neurotrophins, such as pro-NGF and pro-BDNF, to the Sortilin receptor. The invention aims to create medicaments for treating and preventing a range of diseases and disorders, including neurological, neuropsychiatric, and ocular conditions, as well as obesity, diabetes, and pain management. He has 1 patent to his name.
Career Highlights
Anderson is currently associated with H. Lundbeck A/S, a company renowned for its focus on brain diseases. His work at Lundbeck emphasizes the development of therapeutic solutions that can significantly improve patient outcomes in neurodegenerative disorders.
Collaborations
One of his notable collaborators is Anders Nykjaer, with whom he has worked closely on various projects related to neurotrophin modulation.
Conclusion
Olav Michael Anderson's innovative contributions to the field of neurobiology highlight the importance of research in developing treatments for complex diseases. His work continues to pave the way for advancements in medical science.